In many cases, axon growth and guidance are driven by pioneer axons, the first axons to grow in a particular region. Despite their dynamic pathfinding capabilities and developmental importance, there are very few pioneer neuron specific markers and thus their in vivo identification and functional interrogation have been difficult. We found that a Ret receptor isoform, Ret51, is highly enriched in peripheral sensory pioneer neurons and is required for pioneer axon outgrowth. Ret null mutant pioneer neurons differentiate normally; however, they displayed defects in growth cone morphology and formation of filopodia before pioneer axon extension prematurely halts. We also demonstrate loss-of-function of a retrograde cargo adaptor, JNK-interacting protein 3 (Jip3), phenocopied many of these axonal defects. We further found that loss of Jip3 led to accumulation of activated Ret receptor in pioneer growth cones, indicating a failure in the clearance of activated Ret from growth cones. Using an axon sever approach as well as in vivo analysis of axonal transport, we showed Jip3 specifically mediates retrograde, but not anterograde, transport of activated Ret51. Finally, live imaging revealed that Jip3 and Ret51 were retrogradely co-transported in pioneer axons, suggesting Jip3 functions as an adapter for retrograde transport of Ret51. Taken together, these results identify Ret51 as a molecular marker of pioneer neurons and elucidate an important isoform-specific role for Ret51 in axon growth and growth cone dynamics during development.
Introduction
Pioneer neurons are the first to extend axons to a particular region or target, acting as a guide and scaffold for "follower" axons. Pioneer neurons are important in the developing CNS and PNS for the initial navigation to appropriate targets, proper follower axon pathfinding, and promoting follower axon outgrowth. Despite their unique role in neurodevelopment, the molecular program that specifies pioneer neuron identity and regulates their behavior is not well known. Recent studies describe multiple factors, including TAG-1 1 , FMI-1 2 , and AEX-3 3 , that promote pioneer axon growth and pioneer/follower interactions in mouse and C. elegans models. However, these are not exclusive pioneer markers because they are also expressed in follower neurons, too transient to use as a reliable marker for isolating cells or have additional roles in other neuronal subtypes during development. While some progress continues to be made in terms of what factors contribute to pioneer neuron identity and promote some unique axonal properties, specific molecular markers are sorely lacking and act as a barrier to advancing our fundamental understanding of pioneer neuron biology.
In the process of pathfinding, pioneer neuron growth cones must migrate forward, turn, and interact with the local ECM and signaling environment. Dynamic changes in actin cytoskeleton structure in the growth cone are critical for all of these processes. In particular, formation and motility of filopodial protrusions are critical for sensing extrinsic cues for growth cone guidance and are required for proper axon pathfinding and growth cone advancement 4, 5 . One major regulator of axon outgrowth and pathfinding, both during development and following axonal injury, is signaling through neurotrophic factors, including NGF, BDNF, and GDNF. Of these, the best studied neurotrophins are Nerve Growth Factor (NGF) and Brain-derived Growth Factor (BDNF) that signal through the neurotrophin receptors TrkA and TrkB, respectively. NGF and BDNF can have effects locally on axon terminals or signal retrogradely from the axon terminal to the cell body and induce changes in gene expression. For example, NGF and BDNF can induce localized actin polymerization within growth cones, promoting growth cone protrusions through formation of finger-like F-actin bundles, filopodia, or promoting local growth cone "spreading" through formation of a sheet-like actin mesh network, lamellipodia [6] [7] [8] [9] , which is required for growth cone steering and advancement. In contrast, NGF/BDNF long-range retrograde signaling is required for survival of sympathetic neurons, where retrograde transport of active endosomal signaling complexes promotes transcription of pro-survival/anti-apoptotic factors [10] [11] [12] . In addition to survival, retrograde transport of NGF/TrkA promotes sensory axon outgrowth by inducing transcriptional changes in Serum Response Factor 13 , whereas retrograde axonal transport of BDNF/TrkB is required for BDNF-mediated dendritic growth in cortical neurons 14 . In general, however, the transcriptional targets downstream of retrograde neurotrophin signaling that promote axon growth are still largely unknown.
The neurotrophin receptor Ret and its major ligand, Glial cell line-Derived Neurotrophic Factor (GDNF), have established roles in axon growth, enteric nervous system and kidney development, and cancer progression. Ret receptor has two primary expressed isoforms, Ret9 and Ret51, each with a unique amino acid sequence of the intracellular C-terminus. The two isoforms also have different signaling properties and roles during development in vivo. Ret9 is required for proper enteric neuron survival, migration, and differentiation as well as kidney development, while Ret51 is largely dispensable for these processes. Furthermore, monoisoformic RET9 mice (lacking RET51) are viable, while monoisoformic RET51 mice (lacking RET9) die as neonates 15 . These isoforms are also differentially trafficked and have differential susceptibility to degradation in both neurons and non-neuronal cells 16, 17 . In sympathetic neuron culture, RET9 degrades more slowly than RET51, which is thought to allow retrograde trafficking of RET9 and ultimately promote neuronal survival 16 . In human epithelial cell lines, RET9 is transcribed at much higher levels than RET51, but RET51 is comparatively more frequently localized at the plasma membrane, recycled to the plasma membrane after endocytosis, and more rapidly internalized into endosomes after GDNF treatment 17, 18 . Thus, Ret9 and Ret51 have notably different properties and responses to ligand binding even within the same cell.
Ret/GDNF signaling promotes sympathetic 19 , sensory 20 , and motor 21 axon growth and pathfinding. Long-range retrograde RET/GDNF trafficking from distal axons is required for survival of sensory (DRG) neurons and older (15 days in vitro), but not younger (10 days in vitro), sympathetic neurons in rat primary cell cultures 16, 22 . In sympathetic neurons, long-range retrograde transport of GDNF ligand from axon terminals to cell bodies has been observed 22, 23 but, thus far, retrograde transport of GDNF/Ret in sensory neurons has not. Ret/GDNF signaling can also promote sympathetic axon growth in vitro, however, retrograde signaling/transport is not required for this role 16 . Long-range signaling through GDNF/Ret is required for motor neuron extension in developing mouse embryos where loss of GDNF ligand expression in target muscles leads to reduced neuronal expression of Pea3, a transcription factor required for proper cell body positioning and dendrite patterning in the neurons whose axons receive GDNF 24, 25 . However, the mechanisms mediating Ret/GDNF retrograde transport and the full extent of the Ret/GDNF downstream transcriptional response mediating axon growth are unknown and in vivo studies of Ret retrograde transport and signaling are sorely lacking 26 .
In vivo study of long range neurotrophin signaling, receptor transport, and pioneer axon growth is technically challenging. Zebrafish embryos offer a number of advantages for these studies, including optical accessibility, rapid embryonic development, and amenability to transgenesis and genetic manipulation. In this study, we use the long sensory axons of the zebrafish posterior lateral line ganglion (pLLg) neurons because their planar character, superficial localization, and relatively rapid pioneer axon outgrowth make them uniquely suited for live imaging. The pLL senses water movement through mechanical stimulation of sensory organs (neuromasts) that transduce this input through the pLL axons innervating them. During extension, 3 to 6 pLL pioneer axons are guided by the pLL primordium (pLLp), a group of cells that migrate along the trunk from 22 to 48 hours post-fertilization (hpf). Pioneer growth cones typically have longer and more elaborate filopodial protrusions compared to followers and this is the case in pLLg pioneer growth cones, which associate extensively with the migrating pLLp 27 . The pLL primordium expresses GDNF and this ligand production is required for proper pLLg axon outgrowth 28 , but not pLLg neuron specification or survival 28 . This allowed us to explore the specific mechanisms of long-range Ret-mediated axon outgrowth in sensory pioneer neurons.
We find that Ret is specifically expressed in pioneer axons and ret51, but not ret9, isoform is required for pioneer axon outgrowth. In the absence of Ret, pioneer axons display reduced growth cone volume and fewer filopodia, which may underlie the observed pioneer axon outgrowth defects. We also show that JNK-interacting protein 3 (Jip3) is required for retrograde transport of activated Ret51 from pioneer growth cones. In jip3 mutants, retrograde transport of Ret51 is reduced, leading to accumulation of activated Ret in pioneer growth cones. Finally, we observe live retrograde, but not anterograde, co-transport of tagged Ret51 and Jip3 in pioneer sensory axons. This work describes a novel requirement for Ret51 in axon growth and pioneer neuron development and identifies a novel regulator of phosphorylated Ret51 retrograde transport.
Results

Ret expression is elevated in pioneer neurons during axon extension
Previous studies showed that ret is expressed in the pLLg neurons and the Ret ligand GDNF, which is expressed by the pLLp, is required pLLg axon extension 28 . Because Ret receptor isoforms Ret9 and Ret51 have distinct properties, we asked which isoform is required for sensory axon extension. We detected expression of both ret9 and ret51 in the pLLg during pioneer axon outgrowth (30 hours post-fertilization -hpf) by in situ hybridization. ret9 is expressed broadly throughout the pLLg (Fig. 1A) , while ret51 is highly expressed in a subset of the pLLg in the dorsal/anterior region (Fig.1B) .
Based on elevated levels of ret51 mRNA expression in the dorsal region of the ganglion, which was previously attributed to the location of pioneer neurons 29 , we tested whether Ret protein was enriched in extending pioneer neurons. To label cell bodies of the extending pioneer pLLg axons, tails of 40 hpf TgBAC(neurod:EGFP) nl1 transgenic zebrafish embryos (hereafter referred to as neurod:EGFP) 30 were clipped just proximal to the pioneer axon terminals with rhodamine dextran-soaked scissors (Fig. 1C) . After 3 hours, embryos were imaged live to note the location of rhodamine-labeled cell bodies in pLLg, then fixed and immunostained with a-Ret primary antibody (rabbit, for a-Ret antibody validation, see Suppl. Fig. 2 ) and arabbit AlexaFluor 647 secondary (Thermo Fisher) to distinguish a-Ret antibody signal from rhodamine. We found that the majority of rhodamine dextran labeled pioneer axons also displayed high levels of Ret protein (Fig. 1D',E' ). The dorsal localization of the cell bodies positive for Ret and enrichment of ret51 transcript in the same location of the ganglion strongly suggest that Ret51 receptor isoform is specifically expressed in pioneer neurons.
The Ret51 isoform is required for lateral line axon extension
Because Ret is elevated in pioneer neurons during extension, we asked whether Ret activity is required for pioneer axon outgrowth, and, if so, which Ret isoform is necessary for this process. Using the neurod:EGFP transgene to visualize the pLLg axons, we observed that mutants homozygous for the null ret hu2846 allele 31 (which leads to loss of Ret9 and Ret51 isoforms) had disrupted pLLg axon extension, ultimately producing prematurely truncated axons (Fig. 2B) . We observed 97.4% of homozygous ret hu2846 mutants had premature truncation in one or both pLLg axons by 3 dpf (n=89), though we also observed variability in truncation severity between embryo clutches collected from different adult pair matings. However, within a particular clutch, ret hu2846 phenotypes were consistent, as evidenced by the small standard error of the mean of axon truncation in ret hu2846 mutants in subsequent rescue experiments (Fig. 2C,D) . Because of pair to pair variability, we compare ret hu2846 mutant embryos to sibling controls within clutches from individual pair matings. To test if a particular Ret isoform was required for pLLg axon outgrowth, we injected ret hu2846 mutant and sibling embryos from individual clutches with in vitro transcribed human Ret isoform mRNA tagged with mCherry, either RET9-mcherry or RET51-mcherry 18 , at the one-cell stage and assayed at 3 dpf for axon length, measuring the shortest pLLg axon bundle in the embryo as a conservative measure of axon extension rescue (Fig. 2C,D In some cases, RET51 injection produced full-length, bilateral rescue of axon extension (Fig. 2D , 9 of n=87 embryos). This suggests that, in contrast to other developmental contexts such as enteric nervous system and kidney development where Ret9 is necessary but Ret51 is largely dispensable, Ret51 is the critical isoform required for Ret-mediated pLLg axon outgrowth.
Ret is not required for sensory pioneer neuron differentiation, but is necessary for proper growth cone morphology
Because pLLg axon extension is incomplete in ret hu2846 mutants, we examined the cellular bases of this axon growth failure. After initial axon outgrowth and premature termination of axon extension in ret hu2846 mutant embryos, we observed no degeneration or retraction of the partially extended pLLg axons from 48 hpf through 120 hpf (Suppl. Fig. 1 ). To determine if there was a difference in the number of pioneer neurons that extended axons during initial outgrowth, we immunostained ret hu2846 mutants and their wild-type siblings with a-SCG10 antibody at 24 (early outgrowth) or 30 hpf (mid-outgrowth) and imaged distal pLLg axons. SCG10 (STMN2) is enriched in extending sensory pioneer growth cones 32 , serving as a marker of individual pioneer growth cones. Based on SCG10 expression in the distal 100 µm of axons (visualized by the neurod:EGFP transgene) the number of pioneer growth cones that initially extended from the pLLg at 24 : 4.00±0.44, p<0.001). These observations suggest that pLLg pioneer neurons are specified and begin to extend normally; however, axon extension fails after initial outgrowth.
To explore the effect of Ret loss-of-function on pioneer growth cone morphology and behavior, we assayed axon terminals of extending pioneer axon bundles in ret hu2846 mutants and wild-type siblings (Fig. 3A,B) . First, we quantified axonal volume of the distal 75 µm of neurod:EGFP transgenic embryos at 30 hpf which typically contains 5-6 pioneer growth cones (Fig. 3C) . In comparison to siblings, ret hu2846 mutants had significantly reduced distal axonal volume in extending pioneer axon bundles ( Fig. 3C ; wildtype: 1477.6±48.9 µm 3 vs ret hu2846 : 1137.4±136.1, p=0.003). To visualize individual pioneer axon and growth cone morphology, neurod:EGFP embryos at the one-cell stage were injected with plasmid containing the neurod5kb promoter 33 driving mCherry (neurod5kb:mCherry). Injected plasmid distributes mosaically in zebrafish embryos, allowing identification and live imaging of individual pLLg pioneer growth cones expressing mCherry during extension (30 hpf) (Fig. 3A' ,B'). Compared to wild-type siblings, ret hu2846 mutant pioneer growth cones were much less elaborate, had significantly reduced volume ( Fig. 3D; 29, p=0.20) between the two groups. Together, these data show that Ret signaling is required for maintaining proper pioneer growth cone morphology and filopodial numbers but not length.
Jip3 loss-of-function phenocopies loss of Ret signaling
Neurotrophin signaling often involves retrograde transport of the activated receptor-ligand complex from the axon terminal to the cell body. However, the specific trafficking mechanisms are not clearly understood. In the pLLg, JNK-interacting protein 3 (Jip3) functions as a specific retrograde cargo adaptor for Dynein-mediated axonal transport during development 34 . Embryos homozygous for the Jip3 null allele, jip3 nl7 , display pLLg axon extension defects similar to ret hu2846 mutants (Fig. 4B ) 34 . We next asked whether retrograde transport of Jip3 is necessary for the clearance of Ret from the growth cone and axon extension. To test this, we injected EGFP-tagged mRNAs encoding full-length Jip3 (control), Jip3 lacking the p150 binding domain that is unable to interact with the Dynein motor complex 35 (jip3Δp150) or Jip3 lacking the JNK interacting domain 36 (jip3ΔJNK) into 1-cell stage embryos from a heterozygous +/jip3 nl7 mutant incross (Fig. 5G ). Embryos were fixed at 3 days and immunostained for neurofilaments (3A10) to visualize pLLg axons and the proportion of embryos with axon truncation were scored. Expression of a full-length jip3 completely rescued axon truncation at 3 dpf (Fig. 5G , uninjected truncation rate: 17.4%, n=23 vs. jip3: 0%, n=29). Within a clutch, jip3ΔJNK also rescued truncation while jip3Δp150 failed to rescue (uninjected: 15.8%, n=38, jip3ΔJNK: 0%, n=15, jip3Δp150: 22.2%, n=36). Additionally, expression of full-length jip3 mRNA rescued accumulation of pRet in pioneer growth cones (Fig. 5I ) but jip3Δp150 did not (Fig. 5J) . To test if Ret signaling locally regulates JNK activation, we compared immunostaining for pJNK in pioneer growth cones at 30 hpf between ret hu2846 mutants and siblings, but found no significant difference (Suppl. Fig. 4 ). Altogether, these data indicate that the Jip3-p150 interaction is required for Jip3-dependent axon extension and clearance of pRet from pLLg growth cones, suggesting disrupted Ret retrograde transport may underlie the axon truncation observed in jip3 nl7 mutants.
Jip3 mediates retrograde transport of activated Ret51 receptor
Based on these phenotypic similarities and the accumulation of activated Ret in growth cones of jip3 nl7 mutants and the role of Jip3 as a retrograde transport adapter, we asked if Jip3 mediates retrograde transport of Ret. To address this question, we first performed nerve sever experiments 34 as an indirect readout of Ret axonal transport (Fig. 6A-F) . Post nerve sever, anterogradely transported cargoes accumulate in the proximal stump whereas retrogradely transported cargoes accumulate in the distal stump 34 . We hypothesized that if Jip3 specifically mediates retrograde axonal transport of Ret from the growth cone, Ret protein should accumulate at the distal site of nerve sever. Extended pLLg pioneer axons (labled by neurod:EGFP) of siblings and jip3 nl7 mutants were cut between NM 2 and 3 at 5 dpf, allowed to recover for 3h, fixed, and immunostained for total and p905 Ret. Total Ret was detected at the proximal and distal cut sites, indicating that Ret is bidirectionally trafficked in axons. However, the amount of total Ret was not different between wild-type and jip3 nl7 mutant embryos (Fig. 6A-D (Fig. 6C,F, (Fig. 6C') compared to jip3 nl7 mutants, which had much less pRet accumulation at the distal cut site (Fig. 6D',F Next, we tested directly if Jip3 is required for axonal transport of Ret receptor by observing trafficking of Ret fusion protein in extending pLLg axons. To achieve this, we injected plasmid driving mCherry-tagged RET9 or RET51 under the neurod5kb promoter (neurod5kb:RET9/51-mCherry) at the one-cell stage and imaged transport of mCherry-positive particles in extending pLLg axons at 30 hpf 37 . Injected plasmid distributes mosaically in the developing embryo, thus, we can select embryos expressing fusion constructs in 1-3 pLLg neurons to assay Ret trafficking in individual axons during extension. We observed anterograde and retrograde trafficking of mCherry-positive particles in neurod5kb:RET51-mCherry injected embryos, but did not observe any trafficking of discrete mCherry-positive particles with injection of neurod5kb:RET9-mCherry (data not shown). To test whether Jip3 regulates Ret51 retrograde axonal transport in pioneer neurons, we assayed RET51-mCherry transport in jip3 nl7 embryos and wild-type siblings. For our experiments, we used expression of the neurod:EGFP transgene to identify the most distal pLLg pioneer neurons also expressing RET51-mCherry (Fig. 6G,H) . Based on kymograph analysis, we found significantly fewer retrogradely trafficked Ret51-mCherry particles in jip3 nl7 mutant pLLg pioneer neurons compared to wild-type siblings, suggesting a disruption in retrograde transport of Ret51 (Fig. 6G ',H',K). To examine whether transport of other neurotrophin receptors expressed in the pLLg, such as TrkB 38 , was disrupted, we analyzed trafficking of TrkB-mCherry fusion from embryos injected with neurod5kb:trkB-mCherry plasmid (Fig. 6I,J) . Notably, we saw no significant change in trafficking of TrkB-mCherry particles (Fig. 6K,L) . These data, taken together with pRet accumulation in the distal stump of severed jip3 nl7 mutant pLLg axons, strongly argue that Jip3 is required for transport of activated Ret51, but not TrkB, in pLLg axons.
Finally, if Jip3 acts as a specific cargo adaptor for retrograde pRet51 transport, we expect that Jip3 and Ret51 would be co-transported in extending pLLg axons. To address this, we co-injected Tg(BAC)RET51-EGFP and neurod5kb:jip3-mCherry 34 plasmid at one-cell stage and imaged pLLg pioneer axons expressing both fusions at 30 hpf. Co-localization of Jip3-mCherry and RET51-EGFP was observed in a subset of retrogradely trafficked particles but no cases of co-localization were observed for anterogradely transported particles (Fig.7 , Suppl. Mov. 1). Taken together, these data suggest Jip3 preferentially mediates retrograde transport of activated pRet51.
Discussion
The important developmental role of pioneer neurons and their unique axon outgrowth and pathfinding capabilities have led to their study in the CNS and PNS of vertebrates and invertebrates. Despite the wide variety of molecular and genetic tools available for neurobiological research, pioneer neurons are still largely identified at an anatomical level using differences in growth cone morphology, timing of axon outgrowth, or the stereotyped anatomical location of cell bodies in the case of well-mapped nervous systems, such as Drosophila. The lack of a strong, specific molecular or transcriptional marker precludes many avenues of study to elucidate the fundamental neurobiological mechanisms that promote the axon growth and pathfinding behaviors of pioneer neurons. Our work identifies Ret51 as a molecular marker of pioneer sensory neurons and a regulator of pioneer axon outgrowth. We observed high expression of ret51 mRNA specifically in a region of the pLLg neurons known to hold the pioneer neuron cell bodies 29 compared to the broad expression of ret9 throughout the pLLg. Through retrograde dye labeling of pioneer neuron cell bodies, we found an enrichment of Ret receptor protein in pLLg pioneer neuron cell bodies, corresponding to the region of ret51 mRNA expression. ret hu2846 mutants do not have defects in pLLg pioneer neuron specification or survival but do have a failure of continued growth of pioneer axons. This pioneer axon growth was rescued in ret hu2846 mutants by exogenous expression of RET51 mRNA but not RET9, indicating that Ret51 is specifically required for pioneer axon outgrowth. From these data, we conclude Ret51 is a specific marker of pioneer neurons in the pLLg.
A specific role for Ret51 signaling in pioneer axon outgrowth
Ret receptor isoforms have different roles and requirements during development. Ret9 is the critical isoform in the vast majority of cases, most notably in enteric nervous system and kidney development. RET51 is expressed in a specific subset of RET9-expressing sensory neurons in the mouse olfactory system during embryonic development 39 , but the functional consequence of this is unknown. Neuronal studies examining differences in Ret9 and Ret51 subcellular localization and degradation have focused on their roles in neuronal survival 16 . Our work establishes a novel, specific role for Ret51 in pioneer axon extension unrelated to neuronal differentiation or survival and describes in vivo observation of axonal Ret isoform trafficking. Live imaging of RET51/Jip3 retrograde co-transport as well as the disruption of RET51 retrograde axonal transport and pRet localization followed by loss of Jip3, suggests Ret51 retrograde transport may be required for this signaling role. In other cell types, Ret51 is much more rapidly internalized from the plasma membrane and differentially ubiquitylated compared to Ret9 18, 40 . In mouse sympathetic neuron culture, Ret51 is more rapidly degraded in axon terminals compared to Ret9 following GDNF treatment 16 . Interestingly, in DRG sensory neuron cultures, Ret9 was much more highly expressed than Ret51, however, Ret51 was substantially more resistant to degradation and activated Ret51 persisted much longer than in sympathetic neurons, potentially allowing long range axonal transport of Ret51 in sensory neurons. Consistent with these results, loss of Jip3 leads to significant accumulation of pRet receptor in pioneer sensory growth cones, suggesting there is not normally a substantial level of degradation of activated Ret receptor locally. Though we observe broad expression of ret9 throughout pLLg sensory neurons, we were unable to observe axonal trafficking of discrete RET9 particles and RET9 mRNA failed to rescue mutant axon truncation, suggesting retrograde transport of Ret9 is not required for axon growth. It may be that Ret9 has a role in local signaling at the dendrites or cell body that is unrelated to axon outgrowth. After failure of pioneer axon extension in ret hu2846 mutants, we do not observe axonal degeneration or cell death, indicating that, in contrast to the typical role of Ret in cells with stable terminals at their target, Ret9 or Ret51 are not required for neuronal survival at least through day 5 of development.
Jip3 is an adapter for transport of activated Ret
While there is evidence that long distance GDNF signaling is required for motor axon pathfinding 25 , to date there has been no in vivo observation of retrograde axonal trafficking of Ret receptor or description of the mechanisms that would underlie this transport in neurons 26 . GDNF expression from the pLLp, which guides extending pLLg pioneer axons, is required for proper pLLg axon extension 28 , but the mechanisms by which GDNF/Ret mediate this axon extension are unexplored. We found that loss-of-function of a specific axonal retrograde cargo adapter, Jip3, phenocopied pLLg axon truncation and many of the growth cone defects we observed in ret hu2846 mutants. Jip3 can regulate axonal trafficking of another neurotrophin receptor, TrkB 41 , and acts as a retrograde cargo adapter for multiple cargoes in extended pLLg axons 34 , but has not been implicated in Ret receptor transport or signaling. We observed no difference in axon truncation defects in jip3 nl7 and ret hu2846 null double mutants compared to ret hu2846 mutants, indicating that Ret and Jip3 act in the same pathway to promote axon growth. Based on these observations, it is possible Jip3 mediates local Ret signaling in pioneer growth cones, since it also can function as a scaffold that regulates local JNK phosphorylation. However, while Jip3 interaction with JNK has been previously implicated in axon extension 42 , it is not necessary for pLL axon extension 34 and we observe no change in pJNK localization in pioneer growth cones in ret hu2846 mutants. Consistent with this, we found that mRNA injection of full-length Jip3 and Jip3 lacking the JNK-binding domain in jip3 nl7 mutants completely rescued axon truncation and accumulation of pRet in pioneer growth cones, however, Jip3 lacking the p150-binding domain (required for association with the Dynein motor complex) is unable to rescue either phenotype. This suggests Jip3 requires the ability to be retrogradely transported in order to mediate Ret signaling in this context. We observed a significant reduction in the number of retrogradely trafficked Ret51 particles in jip3 nl7 mutants but found normal transport of TrkB in jip3 nl7 mutants. Finally, we observed live retrograde co-transport of Jip3 and Ret51 tagged particles in extending pLLg axons, but no co-transport of anterogradely trafficked particles. We conclude from these data that Jip3 specifically mediates Ret51 retrograde transport. Notably, we did not observe complete loss of retrograde transport of Ret51 in jip3 nl7 mutants or observe complete co-localization of Jip3/Ret51 retrograde transport. This is consistent with our assumption that Jip3 is required for retrograde transport of activated Ret51, which presumably constitutes only a subset of Ret51 fusion visualized in our live trafficking experiments.
Several lines of evidence indicated Jip3 specifically mediates retrograde axonal transport of activated Ret receptor. Immunostaining of extending pioneer pLLg axons for total Ret (tRet) and phospho-905Ret (pRet) revealed a significant accumulation of tRet and pRet in distal tips of pioneer growth cones in Jip3 nl7 mutants. Additionally, this accumulation of pRet in Jip3 nl7 mutants could be rescued by full-length jip3 mRNA injection, but jip3 mRNA lacking the p150-binding domain failed to do so. Our nerve sever experiments found pRet normally accumulated at the distal stump site of wild-type embryos, indicating retrograde transport of activated receptor from axon terminals, but there was significant reduction of pRet signal at the distal stump in jip3 nl7 mutants. Taken together, these results indicate Jip3 mediates retrograde transport of phosphorylated Ret51 in pioneer axons and is required for axon outgrowth and proper formation of growth cone filopodia.
Ret signaling regulates pioneer growth cone morphology and dynamics
Regulated growth cone dynamics, including formation and disassembly of filopodia and lamellipodia, is required for growth cone advancement and axon outgrowth. With Ret loss-of-function, we observe a failure of pioneer axon outgrowth as well as a significant reduction in pioneer growth cone volume. The reduced growth cone volume and more compact morphology of ret mutant growth cones which lacks the typical spread out "footprint" of pioneer growth cones could be caused by defects in formation of lamellipodia, which would ultimately prevent proper growth cone migration and steering. Loss of Ret also led to fewer filopodia per pioneer growth cone but did not change mean length of filopodia. This suggests a defect in initiation of filopodial formation but not maintenance or continued growth. Failure to dynamically form filopodia could disrupt proper interaction with the extracellular environment, particularly the pLLp which is producing GDNF and BDNF 38 , necessary for guiding and promoting axon growth. One explanation for defects in axon outgrowth, then, may be that loss of filopodia leads to less interaction with the pLLp and thus a reduction of trophic/permissive cues sensed from the pLLp, further reducing the formation of growth cone filopodia and producing a positive feedback cycle that ends in failed growth cone advancement. Another non-mutually exclusive possibility is that disruption of dynamic filopodial formation simply prevents proper growth cone motility 43 , leading to failed outgrowth. We conclude, based on the changes we observe in pioneer growth cone morphology that one cellular mechanism underlying failure of axon growth in ret mutants is defective dynamic actin cytoskeletal arrangement which prevents proper growth cone advancement and pathfinding.
Jip3 loss-of-function produces many of the same cellular growth cone phenotypes as Ret loss-of-function. Notably, individual jip3 nl7 mutant pioneer growth cones were not significantly smaller than wild-type, unlike ret hu2846 mutants, which were reduced in volume. This may be explained by terminal pLLg axon swelling that occurs in jip3 nl7 mutants due to failures in retrograde transport of specific cargoes 34 . Such swellings could counteract the reduction of pioneer growth cone volume normally seen with Ret loss-of-function. Alternatively, regulation of this aspect of pioneer growth cone morphology by Ret may either be a local event or otherwise not mediated by Jip3. It is also possible that the accumulation of pRet in jip3 nl7 mutant growth cones leads to high levels of local Ret signaling that may have an additional local impact on growth cone morphology.
While it is clear that Jip3 retrogradely transports pRet, we propose that long range retrograde Ret signaling mediated by Jip3 is required for pioneer axon outgrowth and growth cone dynamics, as opposed to local effects, for several reasons. First, Jip3 and Ret loss-of-function axon truncation and growth cone phenotypes are the same, with the exception of individual growth cone volume, which could be explained by swelling of axon terminals in jip3 nl7 mutants. If it was the case that a local increase in Ret signaling with loss of Jip3 is disruptive to axon outgrowth, we would perhaps expect a difference in axon truncation or filopodial phenotypes compared to ret hu2846 mutants, which we do not observe. Second, there is no difference in the severity of axon truncation in jip3 nl7 / ret hu2846 double mutants compared to individual homozygous mutants, suggesting loss of a Ret retrograde cargo adapter is functionally equivalent to loss of Ret signaling in this case. Third, we observe no local changes in pJNK levels in pioneer growth cones with loss of Ret signaling (Suppl. Fig. 4 ), indicating that Ret does not have a local effect on at least one major pathway that regulates axon growth and growth cone dynamics. Finally, in the case of other neurotrophins, particularly NGF, retrograde axonal transport is coupled with a role in long range retrograde signaling and not simply a clearance of activated/internalized receptor from the growth cone, which can be regulated by local proteasomal degradation (including in the case of Ret) 16, 26, 44 . Based on the established paradigm of retrograde neurotrophin signaling it would be unlikely, then, that activated Ret51 is specifically retrogradely transported along axons without a functional downstream consequence of this transport. Future studies will focus on examining possible effects of high levels of local Ret51 signaling and identifying potential transcriptional targets downstream of Ret retrograde transport and how these regulate specific changes in pioneer growth cone morphology and behavior.
In summary, our in vivo data demonstrate a novel role for Ret51 in pioneer axon extension and suggest the requirement of long-range, retrograde Ret signaling in this process. Additionally, we establish a system to examine the role of neurotrophin signaling in pioneer axon growth without a confounding role in neuronal survival. We identify that Jip3 mediates Ret51 retrograde transport, providing a useful tool to dissect local versus long-range signaling contributions of Ret receptor. Combined with our observation that Ret51 is specifically and highly expressed in pLLg pioneer sensory neurons, we submit that Ret51 functions as a molecular and transcriptional marker of these pioneers. This finding opens up several new technical avenues to examine the mechanisms underlying pioneer neuron development and pathfinding. In particular, this finding can be leveraged with transcriptomic techniques, such as single cell RNA-seq, to study the transcriptional mechanisms that specify pioneer neurons and promote their enhanced axon growth and pathfinding capabilities. Better understanding of the fundamental processes that regulate the unique axonal growth and pathfinding capabilities of pioneer neurons can provide potential therapeutic points of intervention to promote axonal regeneration in response to injury or disease.
Materials and Methods
Zebrafish husbandry
Adult zebrafish were maintained at 28.5°C as previously described and embryos were derived from natural matings or in vitro fertilization 45 , raised in embryo media, and developmentally staged 46 . Strains utilized were AB, TgBAC(neurod:EGFP) nl1 
30
, ret hu2846 31 , and jip nl7 34 .
Plasmids and tagged constructs
Neurod5kb:jip3-mCherry was previously described
34
. Neurod5kb:mCherry plasmid was generated by recombining the neurod5kb promoter 33 p5e entry vector into the pDEST394 vector in the Gateway system by previously described methods 47 . Human RET9-mCherry and RET51-mCherry constructs in the EGFP-N1 vector were obtained from the Mulligan lab 18 and digested with HindIII, NotI, and SphI to release the whole tagged construct and digest the EGFP-N1 vector backbone. Released RET fusion construct cassettes were ligated into HindIII/NotI-digested Gateway pME-MCS vector and subsequently recombined with the neurod5kb or cmv/sp6 promoter p5e entry vectors to yield neurod5kb:RET9/51-mCherry or cmv/sp6:RET9/51-mCherry in the pDEST394 destination vector 47 . Jip3 deletion constructs were derived from pME-Jip3 34 using the Quickchange II kit (Agilent) with the following primers: Δp150forward (GGGAAAGAAGTGGAAAATGAGGAGCTGGAA TCGGTA), Δp150reverse (TTTACCGATTCCAGCTCCTCATTTTCCACTTCTTTC), ΔJNKforward (GAGGAAAAGTAAAACAGGTGGAGATGGCATGGAGGA), ΔpJNKreverse (CCATGCCATCTCCACCTGTTTTACTTTTCCTCCAGT). mRNA was synthesized from Jip3 constructs or cmv/sp6:RET9/51-mCherry using mMessage Machine (Life Technologies) and microinjected at 500 pg/embryo for Jip3 constructs and 50 pg/embryo for RET9/51-mCherry constructs.
Generation of the Ret9-and Ret51-eGFP BAC fusions
We modified a Ret-containing bacterial artificial chromosome (BAC) clone by Escherichia coli-based homologous recombination 48 . BAC clone DKEY-192P21 contains 49.89 kb of sequence upstream and 69.78 kb of sequence downstream of ret (http://www.sanger.ac.uk/Projects/D_rerio/mapping.shtml). After recombination, the modified BAC clone contained an eGFP gene positioned in frame at the 3' end of exon 19 to generate Ret9 fusion or exon 20 to generate Ret51 fusion, following SV40 polyadenylation signal and kanamycin resistance gene. The kanamycin resistance gene was flanked by FLP sites and was removed by FLP-mediated recombination 48 . The accuracy of EGFP integration and FLP recombination were evaluated by PCR, sequencing, and by transient expression assays.
In situ hybridization and wholemount immunostaining RNA in situ hybridization was performed as described 49 . Digoxygenin-labeled antisense RNA probes were generated for ret9 (ensembl: ENSDART00000139237.3) and ret51 (Refseq: NM_181662.2) by amplifying the alternatively spliced 3' exons and 3' UTR of each transcript from cDNA and cloning into pCR4 TOPO (Thermofisher) with the following primers: ret51F (GTCATACCCGAACTGGCCAGA), ret51R (ACTATCGATTGTGTCCACGAT), ret9F (TCCATAGGAAGAGCTGTGATTG), ret9R (GTAAAGACAGGGTTAGTGGCA).
Whole mount immunohistochemistry was performed following established protocols 50 with the following exception: embryos stained with anti-Ret were fixed in Shandon Glyo-Fixx (Thermo Scientific) for one hour at room temperature. The following antibodies were used: anti-GFP (1:1000; Invitrogen #A11122), anti-SCG10 (1:100; ProteinTech, #10586-AP) anti-p905Ret (1:50; Thermo Pierce, #PA517761), anti-Ret (1:100; Santa Cruz, #sc-167), anti-neurofilament (1:500; DSHB, 3A10) anti-pJNK (1∶100; Cell Signaling #9251S). tRet antibody was validated by verifying lack of immunofluorescence signal in pLLg in ret hu2864 mutant embryos compared to wild-type siblings (Suppl. Fig. 2) . pRet antibody was validated by injecting a plasmid construct expressing RET51-mCherry fusion (neurod5kb:RET51-mCherry), identifying embryos with 2-3 pLLg neurons expressing the construct, fixing at 30 hpf, and immunostaining. Co-localization of Ret51-mCherry and pRet was found in extending growth cones, but pRet was largely absent in the ganglion or cell bodies expressing Ret51-mCherry (Suppl. Fig. 3 ), consistent with expectation that only a subpopulation of Ret51 would be phosphorylated and that subpopulation would be enriched in extending growth cones near the source of GDNF ligand. All fluorescently labeled embryos were imaged using a FV1000 laser scanning confocal system (Olympus). Brightfield images were collected using a Zeiss Imager Z1 system. Images were processed using ImageJ software 51 . Brightness and contrast were adjusted in Adobe Photoshop and figures were compiled in Adobe Illustrator.
Quantification of immunofluorescence
For analysis of pRet and tRet intensity in axon terminals and after nerve injury, individuals were immunolabeled as described above. For consistency of labeling, compared larvae were processed in the same batch. Confocal Z-stacks (0.5 µm between planes) were taken of the area of interest using a 40X/NA = 1.3 oil objective with identical settings. Images were analyzed using ImageJ 51 . For fluorescence intensity measurements of pRet or tRet in wildtype and mutant growth cones, summed projections of the regions of interest were generated only through regions that contained the neurod:EGFP signal and converted to 8 bit in ImageJ as previously described 34 . Briefly, in the pLL nerve injury analysis, a 30 µm, neurod:EGFP-positive region encompassing the proximal or distal edge of the severed axon was selected and summed projections through only this segment were compiled for analysis. Prior to statistical comparison, the mean background fluorescent intensity, measured in a region adjacent to the injury site, was subtracted from the values generated.
Growth cone imaging and analysis
For imaging, embryos were mounted in 1.5% low melting point agarose on a glass coverslip, submerged in embryo media containing 0.02% tricaine (MS-222; Sigma) and imaged at 24 or 30 hpf using a 60X/NA = 1.2 water objective on an upright Fluoview1000 confocal microscope (Olympus). The distal 75-125 µm of pLLg axon terminals, indicated by expression of neurod:EGFP transgene, were imaged with stacks of sufficient depth to capture all portions of the terminal axons. For individual growth cone imaging, embryos were injected with neurod5kb:mCherry plasmid, embryos expressing mCherry in 1-2 pLLg neurons with axons extending at or near the axon terminals (marked by neurod:EGFP expression) were selected and imaged as described using 488 and 568 nm excitation channels. Growth cone and collective axon terminal volume was quantified using Imaris software (Bitplane) as follows. We used EGFP signal to generate axonal surfaces based on full stacks and then calculated the volume encapsulated by the surface in a region of interest containing an individual growth cone or the distal 75 µm of collective axon terminals. Filopodia were visualized by creating Zprojections of image stacks of individual growth cones in ImageJ and filopodia were traced using the segmented line tool, measured for length, and filopodia ³ 1µm number and length were scored.
Retrograde axon labeling experiment 40 hpf neurod:EGFP embryos were anesthetized and mounted in 1.2% low melt agarose. Tails were severed with rhodamine dextran-soaked scissors just rostral to pLLp growth cones. Embryos were freed from agarose, allowed to develop for 3 hours, then re-mounted and imaged using an FV1000 confocal microscope. Embryos were subsequently fixed and stained to detect Ret immunoreactivity.
Axon transport analysis
Zygotes were injected with plasmid DNA encoding fluorescently tagged cargos of interest with expression driven by the 5kbneurod promoter 33 and imaged as described above. At 30 hpf, embryos were sorted under epifluorescence to identify individuals with tagged cargo expression in a few cells of the pLL ganglion. For each embryo, a region of interest (30-150 µm) was selected in the pLL nerve in which a long stretch of axon was observable in a single plane. Scans were taken at 3 frames per second for 500-1000 frames. Embryos were subsequently released from agarose and processed for genotyping. For co-transport, embryos expressing both constructs in a single cell were selected and imaged as described above using sequential imaging of the 488 and 568 nm excitation channels. 500 frames were collected at 3 frames per second.
Transport parameters were analyzed using kymograph analysis in the MetaMorph software package (Molecular Devices, Inc.) as previously described 37 . Kymographs containing 10 or more traces were analyzed and each were averaged within individual embryos for statistical analysis. The number of particles moving in each direction was estimated based on traces on the kymographs and then normalized to length of axonal segment and total imaging time.
Axotomy and image acquisition
Five day old zebrafish larvae (neurod:EGFP carriers) were anesthetized in 0.02% tricaine and embedded in 3% methylcellulose on a slide. Pulled thick-walled glass capillaries were used to sever the nerve between NMs 2 and 3. Slides were immersed in Ringer's solution (116 mM NaCl, 2.9 mM KCl, 1.8 mM CaCl2, 5 mM HEPES pH = 7.2, 1% Pen/Strep) and incubated at 28.5°C for 3 hours. Larvae were then collected and immunolabeled for pRet or tRet and EGFP.
Statistical analysis
Data were analyzed with the SPSS software package (IBM). Data suitable for parametric analysis were analyzed using ANOVA with post-hoc Tukey test. Data not suitable for parametric analysis were analyzed using Mann-Whitney U test (Wilcoxon ranked sum test). Axon truncation length measuring within groups over time (Suppl. Fig. 1 ) was analyzed by repeated measures ANOVA with post-hoc Bonferroni test for pairwise comparison. Rescue of Axon truncation length in ret hu2846 mutants by RET9 or RET51 mRNA injection was analyzed by two-way ANOVA with post hoc Tukey test for all experimental conditions within a clutch: uninjected wild-type siblings, RET isoform-injected wild-type siblings, uninjected ret hu2846 mutants, and RET isoform-injected ret hu2846 mutants.
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